Disclosure Panels Details Page

Hepatobiliary Cancers Panel - Disclosures as of 08/17/2018

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Has Attended
Daniel Abbott MD None None None None
Thomas Abrams MD None Aduro Biosciences
Bayer HealthCare
Bristol Myers Squibb
Kaleido Biosciences
Exelixis Inc. None
Steven Alberts MD, MPH None None None None
Daniel Anaya MD None None None None
Robert Anders MD, PhD None Bristol Myers Squibb
Merck & Co., Inc.
None None
Chandrakanth Are MBBS, MBA, FACS, FRCS None None None None -
Al Benson III MD, FACCC, FACP, FASCO None Astellas Pharma US, Inc.
Bayer HealthCare
Bristol Myers Squibb
Eli Lilly and Company
Exelixis Inc.
Genentech, Inc.
Merck & Co., Inc.
Purdue Pharma LP
None None
Marian Birkeland PhD None None None None
Daniel Brown MD, FSIR Sirtex Medical BTG Bard Medical None
Daniel Chang MD Varian Medical Systems, Inc. None None None
Jordan Cloyd MD None None None None
Anne Covey MD None None Accurate Medical None -
Michael D'Angelica MD None None None None
Susan Darlow PhD None None None None
Sarah DeVincenzo PharmD, BCPS None Decision Resources Group Consulting None None
Kristina Gregory MSN, RN None None None None
Lydia Hammond MBA None None None Merck & Co., Inc.
Evelyn Handel PharmD, BCOP, BCPS None None None None
William Hawkins MD Accuronix None Accuronix therapeutics None
Renuka Iyer MD None Bayer HealthCare
Eisai Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
None None -
Rojymon Jacob MD None None Biotheranostics None
Andreas Karachristos MD None None None None
Ann Karosas RPh, BCOP None None None None
Robin Kelley MD Adaptimmune
Agios, Inc.
AstraZeneca Pharmaceuticals LP
Bayer HealthCare
Bristol Myers Squibb
Eli Lilly and Company
Exelixis Inc.
Genentech, Inc.
MedImmune Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Taiho Pharmaceuticals Co., Ltd.
Agios, Inc.
AstraZeneca Pharmaceuticals LP
Bayer HealthCare
Bristol Myers Squibb
Exelixis Inc.
TargetPharma Solutions
None None
Robin Kim MD None None None None
Manisha Palta MD None None Merck & Co., Inc.
Navigant
OAKSTONE CME
UptoDate
None
James Park MD None None None None
Donna Powell DHSc, CMD, RT(T) None None None None
Vaibhav Sahai MBBS, MS Agios, Inc.
Bristol Myers Squibb
Celgene Corporation
Incyte Corporation
Merck & Co., Inc.
NewLink Pharmaceuticals
Celgene Corporation
Halozyme Pharmaceuticals
None None
Tracey Schefter MD None None None None
Jason Sicklick MD Foundation Medicine, Inc.
Novartis Pharmaceuticals Corporation
CarsGen Therapeutics
Grand Rounds
Loxo Oncology
None None
Gagandeep Singh MD None None None None -
Jack Skinner PhD None None None None
Davendra Sohal MD, MPH None Foundation Medicine
Perthera
None None
Stacey Stein MD None Genentech, Inc.
Merck & Co., Inc.
None None
Gary Tian MD, PhD, FACP None Axess Oncology
Cardinal Health
Exelixis Inc.
Incyte Corporation
Janssen Pharmaceutica Products, LP
Merck & Co., Inc.
None None
Jean-Nicolas Vauthey MD None None None None -
Alan Venook MD Halozyme, Inc. AstraZeneca Pharmaceuticals LP
Eisai Inc.
Genentech, Inc.
Roche Laboratories, Inc.
Taiho Pharmaceuticals Co., Ltd.
None None
Andrew Zhu MD, PhD Bayer HealthCare
Bristol Myers Squibb
Eisai Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Blueprint Medicines
Bristol Myers Squibb
Eisai Inc.
Merck & Co., Inc.
None None